Tb
Possibly Resistant Tuberculosis Treatment
search
Possibly Resistant Tuberculosis Treatment
, Possibly Resistant Tb Treatment
See Also
Tuberculosis
Latent Tuberculosis Treatment
Active Tuberculosis Treatment
Susceptible Tuberculosis Treatment
Multiple Drug Resistant Tuberculosis Treatment
Tuberculosis Screening in Children
Tuberculosis Risk Factors
(
Tuberculosis Screening Indications
)
Tuberculosis Risk Factors for progression from Latent to Active Disease
(
Latent Tuberculosis Treatment Indications
)
Tuberculosis Related Chest XRay Changes
Extrapulmonary Tuberculosis
Tuberculin Skin Test
(TST,
Purified Protein Derivative
, PPD)
Mycobacterium Tuberculosis Antigen-Specific Interferon-Gamma Release Assay
(
IGRA
)
Tuberculosis Resources
Indications
Isoniazid
Resistance >4% in patient's community
Human Immunodeficiency Virus
(HIV)
Prior
Tuberculosis
exposure
Precautions
This protocol is from 2003 without available new guidance to use for update as of 2016 review
Multi-drug resistance requires expert local infectious disease opinion for guidance
Management
Initial: Four drug therapy for 2 months
Isoniazid
Rifampin
Pyrazinamide
Ethambutol
or
Streptomycin
Subsequent Dosing
If
Isoniazid
susceptible, treat for 6 months
Isoniazid
Rifampin
If
Isoniazid
resistant THEN
Protocol A: Treat for 6 months
Rifampin
Pyrazinamide
AND
Ethambutol
OR
Streptomycin
Protocol B: Treat for 12 months
Rifampin
Ethambutol
If
Extrapulmonary Tuberculosis
, treat for >9 months
Disseminated tuberculosis
Osteomyelitis
Meningitis
Human Immunodeficiency Virus
(HIV)
If
Tuberculosis
Meningitis
Continue
Pyrazinamide
for full course
Type your search phrase here